3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Lymphoma
2
Breast Neoplasms
2
Thyroid Neoplasms
1
Small Cell Lung Carcinoma
1
Pain, Postoperative
1
Neoplasm, Residual
1
Myelodysplastic Syndromes
1
Multiple Myeloma
1
Malignant Neoplasms of Male Genital Organs
1
Lymphoma, Non-Hodgkin
1
Lymphoma, Follicular
1
Lung Neoplasms
1
Leukemia, Hairy Cell
1
Leukemia
1
Hodgkin Disease
1
Goiter
1
Carcinoma, Small Cell
1
Interventions
6'-fluoro-4',9'-dihydro-N,N-dimethyl-4-phenylspiro(cyclohexane-1,1'(3'H)-pyrano(3,4-b)indol)-4-amine
2
morphine, naltrexone combination
1
Therapeutics
1
Tapentadol
1
Nerve Block
1
Naltrexone
1
Morphine
1
Fentanyl
1
Anesthetics, Local
1
Anesthesia, Local
1
Acceptance and Commitment Therapy
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Chronic Pain
×
Epinephrine
×
Clear all
No trials found.